Creo Medical Group PLC (CREO) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.684x

Based on the latest financial reports, Creo Medical Group PLC (CREO) has a cash flow conversion efficiency ratio of -0.684x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-34.20 Million ≈ $-4.16K USD) by net assets (GBX50.00 Million ≈ $6.08K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Creo Medical Group PLC (CREO) balance sheet quality index to measure how much of total assets are equity-financed.

Creo Medical Group PLC - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Creo Medical Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Creo Medical Group PLC's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Creo Medical Group PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Creo Medical Group PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Geiger Counter Limited LSE:GCL	-0.006x
B Yair Building Corporation 1988 Ltd TA:BYAR	-0.009x
Sentoria Group Bhd KLSE:5213	-3.035x
AI Era Corp. NASDAQ:ABQQD	0.222x
Xplore Resources Corp V:XPLR	0.059x
Arkle Resources PLC STU:48O	-0.027x
Troubadour Resources Inc V:TR	0.017x
Arcandor AG DU:ARO	N/A

Annual Cash Flow Conversion Efficiency for Creo Medical Group PLC (2014–2025)

The table below shows the annual cash flow conversion efficiency of Creo Medical Group PLC from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see CREO company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX50.00 Million ≈ $6.08K	GBX-18.60 Million ≈ $-2.26K	-0.372x	+28.95%
2024-12-31	GBX42.40 Million ≈ $5.16K	GBX-22.20 Million ≈ $-2.70K	-0.524x	-44.96%
2023-12-31	GBX59.80 Million ≈ $7.28K	GBX-21.60 Million ≈ $-2.63K	-0.361x	+28.59%
2022-12-31	GBX49.40 Million ≈ $6.01K	GBX-24.99 Million ≈ $-3.04K	-0.506x	-42.74%
2021-12-31	GBX73.32 Million ≈ $8.92K	GBX-25.98 Million ≈ $-3.16K	-0.354x	-38.36%
2020-12-31	GBX62.81 Million ≈ $7.64K	GBX-16.09 Million ≈ $-1.96K	-0.256x	-83.44%
2019-12-31	GBX82.66 Million ≈ $10.06K	GBX-11.54 Million ≈ $-1.40K	-0.140x	+53.07%
2018-12-31	GBX47.71 Million ≈ $5.81K	GBX-14.20 Million ≈ $-1.73K	-0.298x	+68.83%
2018-06-30	GBX7.33 Million ≈ $891.73	GBX-7.00 Million ≈ $-851.17	-0.955x	-102.27%
2017-06-30	GBX14.65 Million ≈ $1.78K	GBX-6.91 Million ≈ $-841.33	-0.472x	+53.13%
2016-06-30	GBX1.63 Million ≈ $198.22	GBX-1.64 Million ≈ $-199.58	-1.007x	-3.79%
2016-02-29	GBX3.22 Million ≈ $392.03	GBX-3.13 Million ≈ $-380.30	-0.970x	+68.09%
2015-02-28	GBX748.41K ≈ $91.06	GBX-2.27 Million ≈ $-276.80	-3.040x	-206.94%
2014-02-28	GBX1.37 Million ≈ $167.26	GBX-1.36 Million ≈ $-165.64	-0.990x	--

About Creo Medical Group PLC

LSE:CREO UK Medical Devices

Market Cap

$761.02K

GBX6.25 Billion GBX

Market Cap Rank

#30707 Global

#848 in UK

Share Price

GBX12.88

Change (1 day)

-2.83%

52-Week Range

GBX9.90 - GBX17.75

All Time High

GBX243.00